Fair representation of patients with skin of color in melasma trials has signaled a trend toward inclusivity in dermatology, setting a precedent for other indications, according to a study.
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that it ...